Skip to content
Home/Companies/AI/ML/Iambic Therapeutics
Iambic Therapeutics

Iambic Therapeutics

AI/ML·Ireland·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Iambic Therapeutics?

Iambic Therapeutics is an Irish AI/ML company, currently owned by Abingworth since 2023.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Abingworth
Investor
Abingworth
Abingworth Bioventures 8 · 2021 · Life Sciences VC

Key facts

HQIreland
SectorAI/ML
Websitewww.iambic.ai

More from Abingworth Bioventures 8

Other portfolio companies in the same fund.

Cytospire Therapeutics
Cytospire Therapeutics
Active
BiotechUK· 2026
AdvanCell
Active
BiotechAustralia· 2025
Antares Therapeutics
Active
BiotechUS· 2025
Solve Therapeutics
Active
BiotechUS· 2025
Timberlyne Therapeutics
Active
BiotechUS· 2025
Myricx Bio
Myricx Bio
Exited 2026
BiotechUK· 2024
to Novartis

More PE-backed in AI/ML

Comparable ai/ml deals from other GPs.

1715 Labs
Exited 2023
Parkwalk AdvisorsUK
Ai Palette
Ai Palette
Active
AgFunder
AirWorks
AirWorks
Active
PSG EquityUS
Anthropic
Anthropic
Active
General AtlanticUS
ControlExpert
ControlExpert
Active
General AtlanticGermany
Conversica
Conversica
Active
PSG EquityUS

Questions

Who owns Iambic Therapeutics?

Iambic Therapeutics is currently owned by Abingworth, through Abingworth Bioventures 8, since 2023.

When did Abingworth acquire Iambic Therapeutics?

Abingworth acquired Iambic Therapeutics in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue